PARG Antibodies

Santa Cruz Biotechnology features a diverse variety of PARG monoclonal antibodies for advanced research in cellular biology. PARG Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Poly(ADP-ribose) glycohydrolase (PARG) plays a crucial role in regulating cellular responses to DNA damage by hydrolyzing poly(ADP-ribose) chains, reversing the effects of poly(ADP-ribosyl)ation. PARG maintains genomic stability and influences various cellular processes, including DNA repair, cell cycle regulation, and apoptosis. Due to its significance in cancer biology and neurodegenerative diseases, PARG continues to be a target of interest for therapeutic interventions. Researchers worldwide use PARG monoclonal antibodies to investigate cellular pathways and molecular mechanisms. Understanding PARG function contributes to developing new therapeutic strategies for various diseases. PARG research advances our knowledge of DNA repair mechanisms and cell cycle regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to scientific understanding of cellular processes and disease mechanisms.